GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (OTCPK:HAWPF) » Definitions » Total Liabilities

Haw Par (Haw Par) Total Liabilities : $88.0 Mil (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Haw Par Total Liabilities?

Haw Par's Total Liabilities for the quarter that ended in Dec. 2023 was $88.0 Mil.

Haw Par's quarterly Total Liabilities increased from Dec. 2022 ($75.02 Mil) to Jun. 2023 ($81.64 Mil) and increased from Jun. 2023 ($81.64 Mil) to Dec. 2023 ($87.96 Mil).

Haw Par's annual Total Liabilities increased from Dec. 2021 ($52.87 Mil) to Dec. 2022 ($75.02 Mil) and increased from Dec. 2022 ($75.02 Mil) to Dec. 2023 ($87.96 Mil).


Haw Par Total Liabilities Historical Data

The historical data trend for Haw Par's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haw Par Total Liabilities Chart

Haw Par Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.54 48.04 52.87 75.02 87.96

Haw Par Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.87 63.22 75.02 81.64 87.96

Haw Par Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Haw Par's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=66.008+(21.383+0.572
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=88.0

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=2697.379-2609.416
=88.0

Haw Par's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=66.008+(21.383+0.572
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=88.0

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=2697.379-2609.416
=88.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haw Par Total Liabilities Related Terms

Thank you for viewing the detailed overview of Haw Par's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Haw Par (Haw Par) Business Description

Traded in Other Exchanges
Address
401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

Haw Par (Haw Par) Headlines

From GuruFocus

First Eagle Comments on Haw Par

By Holly LaFon Holly LaFon 04-24-2018

Haw Par Stock Is Believed To Be Significantly Overvalued

By GF Value GF Value 03-31-2021

Singapore Based Haw Par Selling at a Discount to NAV

By Holmes Osborne, CFA Holmes Osborne, CFA 07-26-2016